Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering ...

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

Dealing with cancer and its aftermath is never easy, and men tend to fare worse, emotionally and physically. NPR's Yuki Noguchi explores why as part of her series Life After Diagnosis. YUKI NOGUCHI, ...

Immigrants comprise about one-fourth of U.S. doctors, and rural communities rely even more on physicians from overseas. But new immigration policies are making it harder and less appealing for foreign ...